GRFS
Closed
Grifols Sa Adr
9.
0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 9.04
Day's Range: 8.9 - 9.1
Send
sign up or login to leave a comment!
When Written:
7.185
Grifols SA ADR (American Depositary Receipt) is a Spanish multinational pharmaceutical and chemical company that specializes in the production of plasma-derived medicines, diagnostic systems, and hospital pharmacy products. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Grifols operates in over 100 countries worldwide and has a significant presence in the United States, where it operates more than 200 plasma donation centers. The company employs over 20,000 people globally and generated revenues of €5.4 billion in 2020.
Grifols is listed on the Spanish Stock Exchange and also has ADRs listed on the NASDAQ stock exchange in the United States. The ADRs trade under the ticker symbol GRFS and each ADR represents one ordinary share of Grifols SA.
Investors can purchase Grifols ADRs through a brokerage account, and dividends are paid in US dollars. The company has a solid track record of dividend payments and has increased its dividend payout every year since 2013.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Grifols operates in over 100 countries worldwide and has a significant presence in the United States, where it operates more than 200 plasma donation centers. The company employs over 20,000 people globally and generated revenues of €5.4 billion in 2020.
Grifols is listed on the Spanish Stock Exchange and also has ADRs listed on the NASDAQ stock exchange in the United States. The ADRs trade under the ticker symbol GRFS and each ADR represents one ordinary share of Grifols SA.
Investors can purchase Grifols ADRs through a brokerage account, and dividends are paid in US dollars. The company has a solid track record of dividend payments and has increased its dividend payout every year since 2013.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!